Literature DB >> 19517095

[Crystal arthropathies].

M Fuerst1, J Haybaeck, J Zustin, W Rüther.   

Abstract

Basic calcium phosphate (BCP) and calcium pyrophosphate dihydrate crystals are the most common types of pathologic crystals, followed by monosodium urate crystals and, in rare cases, calcium oxalate crystals. These crystals have been associated with a variety of quite different rheumatic syndromes. They are responsible for acute synovial inflammation and also contribute to cartilage degradation and bone lesions within the joint. Although understanding of the molecular mechanisms involved in generating the pathologic effects of these crystals has increased, the role of BCP crystals in particular remains poorly understood. The clinical implication of articular deposits of calcium-containing crystals in osteoarthritis is unknown. This review provides an overview of the clinical and pathological changes of these four different types of crystals.

Entities:  

Mesh:

Year:  2009        PMID: 19517095     DOI: 10.1007/s00132-008-1397-z

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  22 in total

1.  The high prevalence of pathologic calcium crystals in pre-operative knees.

Authors:  Beth A Derfus; Jason B Kurian; Jeffrey J Butler; Laureen J Daft; Guillermo F Carrera; Lawrence M Ryan; Ann K Rosenthal
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

2.  Hyperuricemia and incidence of hypertension among men without metabolic syndrome.

Authors:  Eswar Krishnan; C Kent Kwoh; H Ralph Schumacher; Lewis Kuller
Journal:  Hypertension       Date:  2006-12-26       Impact factor: 10.190

3.  Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.

Authors:  Ru Liu-Bryan; Peter Scott; Anya Sydlaske; David M Rose; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2005-09

4.  Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.

Authors:  Charlene J Williams; Yun Zhang; Andrew Timms; Gina Bonavita; Francisco Caeiro; John Broxholme; Jonathan Cuthbertson; Yvonne Jones; Raul Marchegiani; Antonio Reginato; R Graham G Russell; B Paul Wordsworth; Andrew J Carr; Matthew A Brown
Journal:  Am J Hum Genet       Date:  2002-09-17       Impact factor: 11.025

5.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

Review 6.  Crystal-induced arthropathies: recent investigative advances.

Authors:  Michael H Ellman; Michael A Becker
Journal:  Curr Opin Rheumatol       Date:  2006-05       Impact factor: 5.006

7.  Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro.

Authors:  B Derfus; S Kranendonk; N Camacho; N Mandel; V Kushnaryov; K Lynch; L Ryan
Journal:  Calcif Tissue Int       Date:  1998-09       Impact factor: 4.333

8.  Prevalence of the metabolic syndrome in individuals with hyperuricemia.

Authors:  Hyon K Choi; Earl S Ford
Journal:  Am J Med       Date:  2007-05       Impact factor: 4.965

9.  Inorganic pyrophosphate as a regulator of hydroxyapatite or calcium pyrophosphate dihydrate mineral deposition by matrix vesicles.

Authors:  C Thouverey; G Bechkoff; S Pikula; R Buchet
Journal:  Osteoarthritis Cartilage       Date:  2008-07-07       Impact factor: 6.576

10.  Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies.

Authors:  S Nalbant; J A M Martinez; T Kitumnuaypong; G Clayburne; M Sieck; H R Schumacher
Journal:  Osteoarthritis Cartilage       Date:  2003-01       Impact factor: 6.576

View more
  4 in total

Review 1.  [Slowly progressive joint destruction in an older man as expression of hydroxyapatite disease. Case report and literature review].

Authors:  N Zipfel; L Dießel; K-S Delank; G Keyßer; C Schäfer
Journal:  Z Rheumatol       Date:  2020-03       Impact factor: 1.372

Review 2.  [Detritic synovitis and rare skeletal diseases].

Authors:  J Zustin
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

3.  [Indications for tissue biopsy. Diagnostic histopathology in rheumatological diseases].

Authors:  V Krenn; C Poremba; C Dierkes
Journal:  Z Rheumatol       Date:  2012-06       Impact factor: 1.372

4.  [Differential diagnosis of inflammatory arthritis of the hip joint].

Authors:  A Jablonka; R E Schmidt; D Meyer-Olson
Journal:  Unfallchirurg       Date:  2012-11       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.